Using special gels to help stem cells repair damaged spinal discs
Alginate Hydrogels with Tethered IGF-1 Mimicking Peptides to enhance the Therapeutic Potency of Mesenchymal Stem Cells for Intervertebral Disc Repair
This study is looking at a new way to help people with back pain from damaged discs by using special gels that can carry helpful stem cells and growth factors right to the injury, making it easier for the body to heal.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10887977 on NIH RePORTER |
What this research studies
This research focuses on developing injectable hydrogels that can enhance the effectiveness of mesenchymal stem cells (MSCs) in repairing degenerated intervertebral discs (IVDs). The approach involves creating alginate gels that not only serve as carriers for the MSCs but also contain peptides that mimic growth factors like IGF-1, which are crucial for cell survival and tissue repair. By improving the retention and functionality of MSCs in the damaged area, the research aims to promote better healing outcomes for patients with disc degeneration.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing degeneration of the intervertebral discs, which may include those with chronic back pain or related spinal issues.
Not a fit: Patients with acute spinal injuries or those who do not have intervertebral disc degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from intervertebral disc degeneration, potentially reducing pain and improving mobility.
How similar studies have performed: Previous research has shown promise in using cell carriers and growth factor delivery systems for tissue repair, indicating that this approach may be effective.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Huebsch, Nathaniel — Washington University
- Study coordinator: Huebsch, Nathaniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.